The ClearSeq Comprehensive Cancer targets 151 key genes associated with a wide range of cancers, including breast, lung, colorectal, and AML. This panel was developed in collaboration with cancer researchers from Washington University in St Louis, and is designed for deep coverage of target bases for confident variant detection.
The ClearSeq Comprehensive Cancer is compatible with the SureSelect Target Enrichment System, with options of post-capture and pre-capture pooling available.
View more product information
Product Options
ClearSeq Comprehensive Cancer XT
Catalog Code: 5190-8011
Product Unit: 16 Reactions
POA
ClearSeq Comprehensive Cancer XT
Catalog Code: 5190-8012
Product Unit: 96 Reactions
POA
ClearSeq Comprehensive Cancer XT
Catalog Code: 5190-8013
Product Unit: 96 Reactions (Automation)
POA
ClearSeq Comprehensive Cancer XT Plus
Catalog Code: 5190-8014
Product Unit: 16 Reactions
POA
ClearSeq Comprehensive Cancer XT Plus
Catalog Code: 5190-8015
Product Unit: 96 Reactions
POA
ClearSeq Comprehensive Cancer XT Plus
Catalog Code: 5190-8016
Product Unit: 96 Reactions (Automation)
POA
ClearSeq Comprehensive Cancer XT2
Catalog Code: 5190-8018
Product Unit: 96 Reactions
POA
ClearSeq Comprehensive Cancer XT2
Catalog Code: 5190-8019
Product Unit: 96 Reactions (Automation)
POA
ClearSeq Comprehensive Cancer XT2 Plus
Catalog Code: 5190-8021
Product Unit: 96 Reactions
POA
ClearSeq Comprehensive Cancer XT2 Plus
Catalog Code: 5190-8022
Product Unit: 96 Reactions (Automation)
POA
Follow us